Medigen Vaccine Biologics Corporation
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Charles_Chen
|
| gptkbp:collaboratedWith |
gptkb:National_Institutes_of_Health_(NIH)
gptkb:Dynavax_Technologies |
| gptkbp:country |
gptkb:Taiwan
|
| gptkbp:founded |
2012
|
| gptkbp:headquarters_location |
gptkb:Taipei,_Taiwan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Medigen Vaccine Biologics Corporation
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableWork |
COVID-19 vaccine development
|
| gptkbp:product |
gptkb:MVC-COV1901
vaccines |
| gptkbp:stockExchange |
gptkb:Taipei_Exchange
|
| gptkbp:stockSymbol |
6547
|
| gptkbp:website |
https://www.medigenvac.com/
|
| gptkbp:bfsParent |
gptkb:Medigen
|
| gptkbp:bfsLayer |
7
|